Childhood interleukin-6, C-reactive protein and atopic disorders as risk factors for hypomanic symptoms in young adulthood: A longitudinal birth cohort study

Psychological Medicine

Volumn 47, Issue 1, 2017, Pages 23-33

  Hayes, J F ^a   Khandaker, G M ^b   Anderson, J ^c   MacKay, D ^c   Zammit, S ^d,e   Lewis, G ^a   Smith, D J ^c   Osborn, D P J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Atopic disorders; cohort studies; hypomania; inflammation

Indexed keywords

C REACTIVE PROTEIN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6;

ADOLESCENT; ADULT; ASTHMA; BIPOLAR DISORDER; BLOOD; CHILD; ECZEMA; HUMAN; LONGITUDINAL STUDY; RISK FACTOR; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; ASTHMA; BIPOLAR DISORDER; C-REACTIVE PROTEIN; CHILD; ECZEMA; HUMANS; INTERLEUKIN-6; LONGITUDINAL STUDIES; RISK FACTORS; UNITED KINGDOM; YOUNG ADULT;

EID: 84980349780     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291716001574     Document Type: Article

References (59)

1. Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD, Skeppar P, Vieta E, Scott J (2005). The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. Journal of Affective Disorders 88, 217-233.
2. Angst J, Cassano G (2005). The mood spectrum: improving the diagnosis of bipolar disorder. Bipolar Disorders 7 (Suppl. 4), 4-12.
3. Arif AA, Delclos GL, Colmer-Hamood J (2007). Association between asthma, asthma symptoms and C-reactive protein in US adults: data from the National Health and Nutrition Examination Survey, 1999-2002. Respirology 12, 675-682.
4. Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, Williams H; ISAAC Phase Three Study Group (2006). Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368, 733-743.
5. Bauer M, Glenn T, Rasgon N, MarshW, Sagduyu K, Grof P, Alda M, Murray G, Munoz R, Quiroz D, Bauer R, Jabs B, Whybrow PC (2011). Decreasing the minimum length criterion for an episode of hypomania: evaluation using self-reported data from patients with bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience 261, 341-347.
6. Benazzi F (2001). Is 4 days the minimum duration of hypomania in bipolar II disorder? European Archives of Psychiatry and Clinical Neuroscience 251, 32-34.
7. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhães PV, Amminger P, McGorry P, Malhi GS (2011). Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience and Biobehavioral Reviews 35, 804-817.
8. BerkM,Williams LJ, Jacka FN, O'Neil A, Pasco JA,Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, Maes M (2013). So depression is an inflammatory disease, but where does the inflammation come from? BMC Medicine 11, 200.
9. Beyer J, Kuchibhatla M, Gersing K, Krishnan KRR (2005). Medical comorbidity in a bipolar outpatient clinical population. Neuropsychopharmacology 30, 401-404.
10. Carvalho AF, Takwoingi Y, Sales PMG, Soczynska JK, Köhler CA, Freitas TH, Quevedo J, Hyphantis TN, McIntyre RS, Vieta E (2015). Screening for bipolar spectrum disorders: a comprehensive meta-analysis of accuracy studies. Journal of Affective Disorders 172, 337-346.
11. Castell JV, Gómez-Lechón MJ, DavidM, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC (1989). Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Letters 242, 237-239.
12. Chen MH, Su TP, Chen YS, Hsu JW, Huang KL, Chang WH, Chen TJ, Bai YM (2014). Higher risk of developing major depression and bipolar disorder in later life among adolescents with asthma: a nationwide prospective study. Journal of Psychiatric Research 49, 25-30.
13. Cornish RP, Henderson J, Boyd AW, Granell R, Van Staa T, Macleod J (2014). Validating childhood asthma in an epidemiological study using linked electronic patient records. BMJ Open 4, e005345.
14. Court H, Forty L, Jones L, Gordon-Smith K, Jones I, Craddock N, Smith DJ (2014). Improving the psychometric utility of the Hypomania Checklist (HCL-32): a Rasch analysis approach. Journal of Affective Disorders 152-154, 448-453.
15. De Hert M, Dekker J, Wood D, Kahl K, Holt R, Möller H-J (2009). Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry 24, 412-424.
16. Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R (2007). Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31, 952-955.
17. Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, Smith GD, Henderson J, Macleod J, Molloy L, Ness A, Ring S, Nelson SM, Lawlor DA (2013). Cohort profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. International Journal ofEpidemiology 42, 97-110.
18. Frommberger UH, Bauer J, Haselbauer P, Fräulin A, Riemann D, Berger M (1997). Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. European Archives of Psychiatry and Clinical Neuroscience 247, 228-233.
19. Goldberg JF, Perlis RH, Bowden CL, Thase ME, Miklowitz DJ, Marangell LB, Calabrese JR, Nierenberg AA, Sachs GS (2009). Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. American Journal of Psychiatry 166, 173-181.
20. Goldstein BI, Collinger KA, Lotrich F, Marsland AL, Gill M-K, Axelson DA, Birmaher B (2011). Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders. Journal of Child and Adolescent Psychopharmacology 21, 479-484.
21. Goodwin RD, Jacobi F, Thefeld W (2003). Mental disorders and asthma in the community. Archives of General Psychiatry 60, 1125-1130.
22. Hardoy MC, Cadeddu M, Murru A, Dell'Osso B, Morosini PL, Calabrese JR, Carta MG (2005). Validation of the Italian version of the 'Mood Disorder Questionnaire' for the screening of bipolar disorders. Clinical Practice and Epidemiology in Mental Health 1, 8.
23. Harrison N (2013). Inflammation and mental illness. Journal of Neurology, Neurosurgery and Psychiatry 84, e1.
24. Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD (2009). Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biological Psychiatry 66, 407-414.
25. Holtmann M, Pörtner F, Duketis E, Flechtner H-H, Angst J, Lehmkuhl G (2009). Validation of the Hypomania Checklist (HCL-32) in a nonclinical sample of German adolescents. Journal of Adolescence 32, 1075-1088.
26. Jerrell JM, McIntyre RS, Tripathi A (2010). A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder. Journal of Clinical Psychiatry 71, 1518-1525.
27. Khandaker G, Zimbron J, Lewis G, Jones P (2013). Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychological Medicine 43, 239-257.
28. Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB (2015). Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry 2, 258-270.
29. Khandaker GM, Dantzer R (2016). Is there a role for immuneto-brain communication in schizophrenia? Psychopharmacology 233, 1559-1573.
30. Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB (2014a). Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 71, 1121-1128.
31. Khandaker GM, Zammit S, Lewis G, Jones PB (2014b). A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence. Schizophrenia Research 152, 139-145.
32. Khandaker GM, Zimbron J, Dalman C, Lewis G, Jones PB (2012). Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophrenia Research 139, 161-168.
33. Kiecolt-Glaser JK, Derry HM, Fagundes CP (2015). Inflammation: depression fans the flames and feasts on the heat. American Journal of Psychiatry 172, 1075-1091.
34. Krishnadas R, Cavanagh J (2012). Depression: an inflammatory illness? Journal of Neurology, Neurosurgery and Psychiatry 83, 495-502.
35. Kunz M, Ceresér KM, Goi PD, Fries GR, Teixeira AL, Fernandes BS, Belmonte-de-Abreu PS, Kauer-Sant'Anna M, Kapczinski F, Gama CS (2011). Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro-and anti-inflammatory balance. Revista brasileira de psiquiatria 33, 268-274.
36. Lewis G, Pelosi AJ, Araya R, Dunn G (1992). Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychological Medicine 22, 465-486.
37. Liang W, Chikritzhs T (2013). Asthma history predicts the risk of affective disorders and anxiety disorders. Health 5, 313-319.
38. Lin T-C, Lee CT-C, Lai T-J, Lee C-T, Lee K-Y, Chen VC-H, Stewart R (2014). Association of asthma and bipolar disorder: a nationwide population-based study in Taiwan. Journal of Affective Disorders 168, 30-36.
39. Meyer TD, Hammelstein P, Nilsson L-G, Skeppar P, Adolfsson R, Angst J (2007). The Hypomania Checklist (HCL-32): its factorial structure and association to indices of impairment in German and Swedish nonclinical samples. Comprehensive Psychiatry 48, 79-87.
40. Meyer TD, Schrader J, Ridley M, Lex C (2014). The Hypomania Checklist (HCL)-systematic review of its properties to screen for bipolar disorders. Comprehensive Psychiatry 55, 1310-1321.
41. Müller N, Schwarz M (2007). The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Molecular Psychiatry 12, 988-1000.
42. Osborn DP, Wright CA, Levy G, King MB, Deo R, Nazareth I (2008). Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis. BMC Psychiatry 8, 84.
43. Päären A, Bohman H, von Knorring A-L, von Knorring L, Olsson G, Jonsson U (2014). Hypomania spectrum disorder in adolescence: a 15-year follow-up of non-mood morbidity in adulthood. BMC Psychiatry 14, 9.
44. Parboosing R, Bao Y, Shen L, Schaefer CA, Brown AS (2013). Gestational influenza and bipolar disorder in adult offspring. JAMA Psychiatry 70, 677-685.
45. Parker G, Graham R, Synnott H, Anderson J (2014). Is the DSM-5 duration criterion valid for the definition of hypomania? Journal of Affective Disorders 156, 87-91.
46. Pedersen MS, Benros ME, Agerbo E, Børglum AD, Mortensen PB (2012). Schizophrenia in patients with atopic disorders with particular emphasis on asthma: a Danish population-based study. Schizophrenia Research 138, 58-62.
47. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmächer T (2001). Cytokine-associated emotional and cognitive disturbances in humans. Archives of General Psychiatry 58, 445-452.
48. Rincon M, Irvin CG (2012). Role of IL-6 in asthma and other inflammatory pulmonary diseases. International Journal of Biological Sciences 8, 1281-1290.
49. Rossi S, Sacchetti L, Napolitano F, De Chiara V, Motta C, Studer V, Musella A, Barbieri F, Bari M, Bernardi G, Maccarrone M, Usiello A, Centonze D (2012). Interleukin-1β causes anxiety by interacting with the endocannabinoid system. Journal of Neuroscience 32, 13896-13905.
50. Sanna L, Stuart AL, Pasco JA, Jacka FN, Berk M, Maes M, O'Neil A, Girardi P, Williams LJ (2014). Atopic disorders and depression: findings from a large, population-based study. Journal of Affective Disorders 155, 261-265.
51. Scheiermann C, Kunisaki Y, Frenette PS (2013). Circadian control of the immune system. Nature Reviews Immunology 13, 190-198.
52. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011). The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1813, 878-888.
53. Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, Cowan JO, Herbison GP, Silva PA, Poulton R (2003). A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. New England Journal of Medicine 349, 1414-1422.
54. Shamssain M (2007). Trends in the prevalence and severity of asthma, rhinitis and atopic eczema in 6-to 7-and 13-to 14-yr-old children from the north-east of England. Pediatric Allergy and Immunology 18, 149-153.
55. Stertz L, Magalhães PV, Kapczinski F (2013). Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Current Opinion in Psychiatry 26, 19-26.
56. Takemura M, Matsumoto H, Niimi A, Ueda T, Matsuoka H, Yamaguchi M, Jinnai M, Muro S, Hirai T, Ito Y, Nakamura T (2006). High sensitivity C-reactive protein in asthma. European Respiratory Journal 27, 908-912.
57. TimonenM, Jokelainen J, Hakko H, Silvennoinen-Kassinen S, Meyer-Rochow V, Herva A, Räsänen P (2003). Atopy and depression: results from the Northern Finland 1966 birth cohort study. Molecular Psychiatry 8, 738-744.
58. Wenzel SE (2006). Asthma: defining of the persistent adult phenotypes. Lancet 368, 804-813.
59. ZimmermannP, BrücklT,NoconA,PfisterH,LiebR,Wittchen H-U, Holsboer F, Angst J (2009). Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Archives of General Psychiatry 66, 1341-1352.